Navigation Links
Palomar to Unveil New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery
Date:3/28/2008

contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on the Company's current expectations, plans, intentions, beliefs or predictions. These forward-looking statements are neither promises nor guarantees, but involve risk and uncertainties that may individually or mutually impact the matters herein, and cause actual results, events and performance to differ materially from such forward-looking statements. These risk factors include, but are not limited to, results of future operations, technological difficulties in developing or introducing new products, the results of future research, lack of product demand and market acceptance for current and future products, the effect of economic conditions, challenges in managing joint ventures and research with third parties and government contracts, the impact of competitive products and pricing, governmental regulations with respect to medical devices, including whether FDA clearance will be obtained for future products and additional applications, the results of litigation, including patent infringement lawsuits, difficulties in collecting royalties, potential infringement of third-party intellectual property rights, factors affecting the Company's future income and resulting ability to utilize its NOLs, and/or other factors, which are detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended December 31, 2007 and the Company's quarterly reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward- looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contacts: Kayla Castle

<
'/>"/>
SOURCE Palomar Medical Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast
2. Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
3. Palomar to Debut New Technology at the American Academy of Dermatology Annual Meeting
4. Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
5. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
6. Wellcorps International Unveils New Nutritional Supplements
7. Edwards Plan on AIDS Unveiled Today
8. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
9. Rice unveils $100 million initiative for world health technology
10. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
11. Aloka to Unveil New ProSound Diagnostic Ultrasound System at the 17th World Congress on Ultrasound in Obstetrics and Gynecology, 7th to 11th of October 2007 in Florence, Italy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... For the second ... be featured in the list of the 50 fastest growing companies in Jacksonville. This ... the business community. On July 16th, a team of Vast Bridges staffers were on ...
(Date:7/29/2015)... ... ... in full swing, which means bridal beauty prep is officially in overdrive. With the excitement ... bride wants to look and feel beautiful, but a recent study suggests that brides-to-be are ... by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) , reveals ...
(Date:7/29/2015)... ... , ... CanAm Enterprises, LLC (“CanAm”) is thrilled to announce that more than ... been granted to investors in four different CanAm EB-5 projects -- the Sony and ... and the Valley Forge Convention Center project in CanAm’s regional center in partnership with ...
(Date:7/29/2015)... , ... July 29, 2015 , ... July is National UV Awareness Month, and in ... DC shares tips on how to protect skin from the sun, as well as how ... cancer, and is one of the most common skin conditions in America. Many people do ...
(Date:7/29/2015)... ... July 29, 2015 , ... A June 10, 2015 ... Skin Cancer ," discussed the importance of having regular skin cancer screenings from an ... excessive exposure to ultraviolet rays. When caught early, skin cancer is rarely fatal; however, ...
Breaking Medicine News(10 mins):Health News:Vast Bridges Continues Its Swift Growth 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3
... , WASHINGTON, Dec. 22 St. John Health System, ... United States $13,229,348.88 to settle allegations that it violated ... , The United Sates alleges that St. John ... by the hospital,s financial relationships with referring physicians. Specifically, ...
... ... advanced warning system and self-generated alerts are the backbone of our EHR,” says Kepila. ... is automatically posted by The CareData Solution to the patient and the provider,s PHR, ... ...
... , PRINCETON, NJ, Dec. 22 ... NCST ) is pleased to announce the closing of ... assets of Nucryst pursuant to an asset purchase agreement ... Pharmaceuticals Inc., Smith & Nephew Inc. and Smith & ...
... menstrual pain, migraines and acne may be other ... Dec. 22 (HealthDay News) -- Along with preventing ... as severe menstrual pain and heavy menstrual bleeding, ... the American College of Obstetricians and Gynecologists. , ...
... ... development and strategic consulting firm, won a coveted Brandon Hall silver award for ... ... About the Winning e-Learning Course: The award-winning “APEX-Optics Bronze Certification” custom e-learning course, ...
... , SHENZHEN, China, Dec. 22 /PRNewswire-FirstCall/ - ... to announce that it has an agreement in principle to ... medicine company in China. The buyer, founded in 2004, focuses ... herbal preparations. Name of the buyer will be announced in ...
Cached Medicine News:Health News:Oklahoma Hospital Group Pays U.S. $13 Million to Settle False Claims Act Allegations 2Health News:CareData Solutions EHR v2.7, Receives Full CCHIT Certification 2Health News:NUCRYST Announces the Completion of the Sale of its Acticoat Business 2Health News:NUCRYST Announces the Completion of the Sale of its Acticoat Business 3Health News:NUCRYST Announces the Completion of the Sale of its Acticoat Business 4Health News:The 'Pill' Offers Benefits Beyond Birth Control 2Health News:Allen Interactions Receives Silver Brandon Hall Learning Award 2Health News:Allen Interactions Receives Silver Brandon Hall Learning Award 3Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 2Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 3Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 4
(Date:7/29/2015)... NEW YORK , July 29, 2015 ... releases a new research report "Global Industry ... Forecast to 2020" with market overview, trends, DRO ... porter analysis, recent developments, competitive scenario and ... http://photos.prnewswire.com/prnh/20150727/756778 ) Microfluidic ...
(Date:7/29/2015)... , July 29, 2015 Commenting ... transaction closed, CFO Simon Dingemans reveals sales ... are performing in line with expectations. Ahead of a ... to sustainable innovation. The interview and transcript ... MerchantCantos produces in-depth interviews, documentaries and webcasts with senior ...
(Date:7/29/2015)... July 29, 2015  Cepheid (Nasdaq: CPHD ... update to Xpert® Carba-R, with the addition of ... The on-demand, molecular test also detects and differentiates ... resistance, namely KPC, NDM, VIM, IMP-1 and OXA-48. ... CROs or Superbugs, are a growing and expensive ...
Breaking Medicine Technology:Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 3Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 4Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 5'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4
... of clinical trials, ... including exposure and required coverage, CHICAGO, Aug. 13 ... (NYSE: AOC ) and the leading provider of,global ... a new,Clinical Trials module as part of RiskConsole, the ...
... with ISIS 353512 could provide therapeutic benefit in ... cardiovascular, renal and inflammatory diseases, CARLSBAD, Calif., ... announced today it has initiated a,Phase 1 study of ... C-reactive protein (CRP). CRP levels are frequently elevated,in patients ...
Cached Medicine Technology:Aon eSolutions Launches Clinical Trials Module 2Aon eSolutions Launches Clinical Trials Module 3Aon eSolutions Launches Clinical Trials Module 4Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
The Aescula LV left-heart lead is a stylet-driven, silicone insulated lead with a titanium nitride (TiN) coated platinum-iridium electrode....
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
... The Guidant Flextend ... transvenous pace/sense lead with ... The extendable/retractable helix design ... possibilities for permanent implantation ...
Medicine Products: